CA2340343C - Enantioselective synthesis - Google Patents

Enantioselective synthesis Download PDF

Info

Publication number
CA2340343C
CA2340343C CA002340343A CA2340343A CA2340343C CA 2340343 C CA2340343 C CA 2340343C CA 002340343 A CA002340343 A CA 002340343A CA 2340343 A CA2340343 A CA 2340343A CA 2340343 C CA2340343 C CA 2340343C
Authority
CA
Canada
Prior art keywords
formula
compound
temperature
produce
acid addition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002340343A
Other languages
English (en)
French (fr)
Other versions
CA2340343A1 (en
Inventor
Richard W. Draper
Radha V. Iyer
Yuelie Lu
Eugene J. Vater
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp & Dohme LLC
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of CA2340343A1 publication Critical patent/CA2340343A1/en
Application granted granted Critical
Publication of CA2340343C publication Critical patent/CA2340343C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/26—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with aromatic rings attached in position 2 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/32—Antioestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/60—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with aryl radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
CA002340343A 1998-08-14 1999-08-12 Enantioselective synthesis Expired - Fee Related CA2340343C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13421698A 1998-08-14 1998-08-14
US09/134,216 1998-08-14
PCT/US1999/016711 WO2000009493A1 (en) 1998-08-14 1999-08-12 Enantioselective synthesis

Publications (2)

Publication Number Publication Date
CA2340343A1 CA2340343A1 (en) 2000-02-24
CA2340343C true CA2340343C (en) 2007-04-24

Family

ID=22462296

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002340343A Expired - Fee Related CA2340343C (en) 1998-08-14 1999-08-12 Enantioselective synthesis

Country Status (10)

Country Link
EP (1) EP1104414B1 (enExample)
JP (2) JP3684332B2 (enExample)
CN (1) CN1146554C (enExample)
AT (1) ATE232525T1 (enExample)
AU (1) AU5459399A (enExample)
CA (1) CA2340343C (enExample)
DE (1) DE69905376T2 (enExample)
ES (1) ES2188222T3 (enExample)
WO (1) WO2000009493A1 (enExample)
ZA (1) ZA200100875B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3205648A1 (en) 2010-06-10 2017-08-16 Seragon Pharmaceuticals, Inc. Estrogen receptor modulators and uses thereof
EP2791132A4 (en) 2011-12-14 2015-08-05 Seragon Pharmaceuticals Inc ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
BR112014014767A2 (pt) 2011-12-16 2017-06-13 Olema Pharmaceuticals Inc novos compostos de benzopirano, composições e usos dos mesmos

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395842A (en) * 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
US5254568A (en) * 1990-08-09 1993-10-19 Council Of Scientific & Industrial Research Benzopyrans as antiestrogenic agents
US6060503A (en) * 1991-12-02 2000-05-09 Endorecherche, Inc. Benzopyran-containing compounds and method for their use
US5407947A (en) * 1993-11-05 1995-04-18 Eli Lilly And Company Methods for inhibiting bone loss using pyrolidine and piperidine substituted benzopyrans
AU8102398A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute (dl)-2,3-diaryl-2h-1-benzopyrans
AU8102498A (en) * 1997-07-09 1999-02-08 Central Drug Research Institute Preparation of diaryl-benzopyrans
US6465445B1 (en) * 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors

Also Published As

Publication number Publication date
ES2188222T3 (es) 2003-06-16
WO2000009493A1 (en) 2000-02-24
JP2002522533A (ja) 2002-07-23
CN1322200A (zh) 2001-11-14
CN1146554C (zh) 2004-04-21
AU5459399A (en) 2000-03-06
JP3684332B2 (ja) 2005-08-17
ATE232525T1 (de) 2003-02-15
JP4461048B2 (ja) 2010-05-12
ZA200100875B (en) 2002-06-26
CA2340343A1 (en) 2000-02-24
DE69905376D1 (de) 2003-03-20
HK1036978A1 (en) 2002-01-25
DE69905376T2 (de) 2003-10-09
JP2005206610A (ja) 2005-08-04
EP1104414A1 (en) 2001-06-06
EP1104414B1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
HUE025904T2 (en) Methods for purifying trans-(-)-delta9-tetrahydrocannabinol and trans-(+)-delta9-tetrahydrocannabinol
FR2963006A1 (fr) Procede de preparation de derives de nitro-benzofurane
US8288569B2 (en) Carbonyl asymmetric alkylation
US7737303B2 (en) Production of chirally pure amino alcohol intermediates, derivatives thereof, and uses thereof
AU2006346311B2 (en) A process for preparation of racemic Nebivolol
ES2391830T3 (es) Un procedimiento para la preparación de Nebivolol racémico
EP1776354B1 (en) A novel process for preparation of nebivolol intermediates
US6262270B1 (en) Enantioselective synthesis
JP2009523749A5 (enExample)
US12006275B2 (en) Process for making levoamphetamine
JP5255765B2 (ja) エントリシタビンを製造するための方法及び中間体
EP1104414B1 (en) Enantioselective synthesis
MXPA05006783A (es) Un proceso para la preparacion de diol de citalopram racemico y/o dioles de citalopram s o r y el uso de tales dioles para la preparacion de citalopram racemico, citalopram r y/o citalopram s.
CN109456253B (zh) 一种手性诱导合成(s)-3-(4-溴苯基)-哌啶或其盐的方法
KR100672790B1 (ko) 에리스로-3-아미노-2-히드록시부티르산 유도체의 제조 방법
US6846957B2 (en) Synthesis of 3-aminomethyl-1-propanol, a fluoxetine precursor
HK1036978B (en) Enantioselective synthesis
JP5406194B2 (ja) Ｒ−ゴシポールｌ−フェニルアラニノールジエナミンを調製するための方法
JPH11504650A (ja) アルファ−（置換アルキルフェニル）−４−（ヒドロキシジフェニルメチル）−１−ピペリジンブタノール誘導体、その製造および抗ヒスタミン剤、抗アレルギー剤および気管支拡張剤としてのその使用
MXPA01001643A (es) Sintesis enantioselectiva
US4201870A (en) Process for the preparation of 2-(3-benzoylphenyl)-propionic acid
EP2907810A1 (en) A new method for producing nebivolol hydrochloride of high purity
JP2000198779A (ja) ３―アルキルフラバノノ―ル誘導体の精製法
US6281379B1 (en) Process for producing norstatin derivatives
WO2026087677A1 (en) Enantioselective synthesis of (s)-afoxolaner and solid forms of (s)-afoxolaner

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20180813